Bolt Biotherapeutics Stock Target Price and Analyst Consensus

BOLT Stock  USD 0.63  0.03  5.00%   
The current analyst and expert consensus on Bolt Biotherapeutics is Hold with 4 hold recommendations. The current projected Bolt Biotherapeutics target price consensus is 5.00 with 4 analyst opinions. One of the most common ways Bolt Biotherapeutics analysts use to provide buy-or-sell recommendation to the public are conference calls analysis and financial statements evaluations. Some experts can also talk to Bolt Biotherapeutics vendors, executives, and/or customers. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on Bolt Biotherapeutics. We encourage you to use your own analysis of Bolt Biotherapeutics to validate this buy or sell advice. Bolt Biotherapeutics recommendation module provides expert sentiment on the projected Bolt Biotherapeutics target price to derive its highest and lowest estimates based on target price standard deviation of 2.5915.
Lowest Forecast
4.55
Highest Forecast
5.55
Target Price
5
At this time, Bolt Biotherapeutics' Gross Profit is comparatively stable compared to the past year. Gross Profit Margin is likely to gain to 0.80 in 2024, whereas Pretax Profit Margin is likely to drop (9.23) in 2024. At this time, Bolt Biotherapeutics' Long Term Investments are comparatively stable compared to the past year.
  
It's important to approach Bolt Biotherapeutics' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.

Steps to utilize Bolt Biotherapeutics price targets

Bolt Biotherapeutics' stock target price is an estimate of its future price, usually made by analysts. Using Bolt Biotherapeutics' target price to determine if it is a suitable investment can be done through the following steps:
  • Look at Bolt Biotherapeutics' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
  • Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
  • Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
  • Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Bolt Biotherapeutics' stock is likely to perform well.
  • Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Remember that stock target prices are just estimates and are subject to change. Therefore, using them as one factor in a larger investment strategy is essential rather than relying solely on them to make decisions.

Additional Bolt Biotherapeutics Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Bolt Biotherapeutics is a key component of Bolt Biotherapeutics valuation and have some predictive power on the future returns of a Bolt Biotherapeutics.
Hype
Prediction
LowEstimatedHigh
0.030.633.22
Details
Intrinsic
Valuation
LowRealHigh
0.081.704.29
Details
Naive
Forecast
LowNextHigh
0.010.653.24
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.39-0.38-0.36
Details

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Macroaxis Index Idea
Macroaxis Index
Invested few shares
Driverless Cars Idea
Driverless Cars
Invested few shares
Social Domain Idea
Social Domain
Invested few shares
Artificial Intelligence Idea
Artificial Intelligence
Invested few shares
Momentum Idea
Momentum
Invested over 50 shares
Investor Favorites Idea
Investor Favorites
Invested over 60 shares
Warren Buffett Holdings Idea
Warren Buffett Holdings
Invested few shares
Business Services Idea
Business Services
Invested few shares
Automobiles and Trucks Idea
Automobiles and Trucks
Invested over 200 shares
ESG Investing Idea
ESG Investing
Invested few shares
Adviser Favorites Idea
Adviser Favorites
Invested few shares

Additional Tools for Bolt Stock Analysis

When running Bolt Biotherapeutics' price analysis, check to measure Bolt Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bolt Biotherapeutics is operating at the current time. Most of Bolt Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Bolt Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bolt Biotherapeutics' price. Additionally, you may evaluate how the addition of Bolt Biotherapeutics to your portfolios can decrease your overall portfolio volatility.